|Bid||127.70 x 800|
|Ask||128.01 x 1000|
|Day's range||126.99 - 127.92|
|52-week range||120.40 - 174.16|
|Beta (5Y monthly)||1.02|
|PE ratio (TTM)||9.71|
|Earnings date||19 Oct 2022 - 24 Oct 2022|
|Forward dividend & yield||2.64 (1.93%)|
|Ex-dividend date||05 Jul 2022|
|1y target est||144.86|
Quest Diagnostics in its latest media report notes that demand for COVID-19 molecular diagnostic testing declined in August compared to the prior month.
Readers hoping to buy Quest Diagnostics Incorporated ( NYSE:DGX ) for its dividend will need to make their move...
Quest Diagnostics (DGX) inked a new agreement to deliver high-quality diagnostics services for a renowned healthcare provider in Southwest Florida.